Correction to: PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors

Affiliations

• ¹ Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. juquint@email.unc.edu.
• ² Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ³ Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ⁴ Bayer Health Care Pharmaceuticals, Whippany, NJ, USA.
• ⁵ Department of Medicine, The University of Chicago, Chicago, IL, USA.
• ⁶ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
• ⁷ Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
• ⁸ Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. federico.innocenti@abbvie.com.